https://doi.org/10.1182/blood.2022015850
J
Jürgen Thiele
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
113
Papers
17.5K
Citations
35
h-index
64
i10-index
Jürgen Thiele is an academic researcher from University of Cologne. The author has contributed to research in topics: Myeloproliferative Neoplasms: Diagnosis and Treatment & Acute Myeloid Leukemia Research & Chronic Myeloid Leukemia Treatments. The author has an h-index of 35, co-authored 97 publications.
Papers by this author
worksInternational Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data
2022 · Blood · 2,486 citations
Long-term effects of ruxolitinib versus best available therapy on bone marrow fibrosis in patients with myelofibrosis
2018 · Journal of Hematology & Oncology · 81 citations
https://doi.org/10.1186/s13045-018-0585-5
Effect of treatment with a JAK2-selective inhibitor, fedratinib, on bone marrow fibrosis in patients with myelofibrosis
2015 · Journal of Translational Medicine · 42 citations
https://doi.org/10.1186/s12967-015-0644-4
The new WHO classification for essential thrombocythemia calls for revision of available evidences
2020 · Blood Cancer Journal · 25 citations
https://doi.org/10.1038/s41408-020-0290-9
Evolution of WHO diagnostic criteria in “Classical Myeloproliferative Neoplasms” compared with the International Consensus Classification
2025 · Blood Cancer Journal · 9 citations
https://doi.org/10.1038/s41408-025-01235-7
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat